TY - JOUR
T1 - Evolution of the gynecologic oncology group protocols in the treatment of epithelial ovarian cancer
AU - Seamon, Leigh G.
AU - Richardson, Debra L.
AU - Copeland, Larry J.
PY - 2012/3
Y1 - 2012/3
N2 - This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).
AB - This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).
KW - GOG
KW - Gynecologic Oncology Group
KW - clinical trials
KW - ovarian cancer
KW - review
UR - http://www.scopus.com/inward/record.url?scp=84857596702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857596702&partnerID=8YFLogxK
U2 - 10.1097/GRF.0b013e318248050d
DO - 10.1097/GRF.0b013e318248050d
M3 - Review article
C2 - 22343234
AN - SCOPUS:84857596702
SN - 0009-9201
VL - 55
SP - 131
EP - 135
JO - Clinical Obstetrics and Gynecology
JF - Clinical Obstetrics and Gynecology
IS - 1
ER -